Merck
  • Home
  • Search Results
  • Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.

Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.

Journal of cellular and molecular medicine (2014-10-22)
Yang Guo, Andreas Ziesch, Sandra Hocke, Eric Kampmann, Stephanie Ochs, Enrico N De Toni, Burkhard Göke, Eike Gallmeier
ABSTRACT

We previously established a role for HSP27 as a predictive marker for therapeutic response towards gemcitabine in pancreatic cancer. Here, we investigate the underlying mechanisms of HSP27-mediated gemcitabine sensitivity. Utilizing a pancreatic cancer cell model with stable HSP27 overexpression, cell cycle arrest and apoptosis induction were analysed by flow cytometry, nuclear staining, immunoblotting and mitochondrial staining. Drug sensitivity studies were performed by proliferation assays. Hyperthermia was simulated using mild heat shock at 41.8°C. Upon gemcitabine treatment, HSP27-overexpressing cells displayed an early S-phase arrest subsequently followed by a strongly increased sub-G1 fraction. Apoptosis was characterized by PARP-, CASPASE 3-, CASPASE 8-, CASPASE 9- and BIM- activation along with a mitochondrial membrane potential loss. It was reversible through chemical caspase inhibition. Importantly, gemcitabine sensitivity and PARP cleavage were also elicited by heat shock-induced HSP27 overexpression, although to a smaller extent, in a panel of pancreatic cancer cell lines. Finally, HSP27-overexpressing pancreatic cancer cells displayed an increased sensitivity also towards death receptor-targeting agents, suggesting another pro-apoptotic role of HSP27 along the extrinsic apoptosis pathway. Taken together, in contrast to the well-established anti-apoptotic properties of HSP27 in cancer, our study reveals novel pro-apoptotic functions of HSP27-mediated through both the intrinsic and the extrinsic apoptotic pathways-at least in pancreatic cancer cells. HSP27 could represent a predictive marker of therapeutic response towards specific drug classes in pancreatic cancer and provides a novel molecular rationale for current clinical trials applying the combination of gemcitabine with regional hyperthermia in pancreatic cancer patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
水, Nuclease-Free Water, for Molecular Biology
Sigma-Aldrich
水, suitable for HPLC
Sigma-Aldrich
水, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
水, HPLC Plus
Supelco
水, suitable for ion chromatography
Sigma-Aldrich
水, deionized
Sigma-Aldrich
水, for molecular biology, sterile filtered
Sigma-Aldrich
水, for embryo transfer, sterile-filtered, BioXtra, suitable for mouse embryo cell culture
Sigma-Aldrich
氰化羰基-3-氯苯腙, ≥97% (TLC), powder
Supelco
水, for TOC analysis
Supelco
水, ACS reagent, for ultratrace analysis
纯水密度标准物质RM, 0.9982 g/mL(20 °C), UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Sigma-Aldrich
水, BioPerformance Certified
Sigma-Aldrich
水, for cell biology, sterile ultrafiltered
Sigma-Aldrich
缬氨霉素, ≥98% (TLC), ≥90% (HPLC)
Supelco
钾离子载体 I, Selectophore, function tested
Sigma-Aldrich
水, PCR Reagent
Sigma-Aldrich
水, ACS reagent
Sigma-Aldrich
JC-1, solid
水, UKAS ISO/IEC17025 and ISO Guide 34 certified, density: 0.9982 g/mL at 20 °C, density: 0.9970 g/mL at 25 °C
Sigma-Aldrich
缬氨霉素, ≥99.0% (TLC)
Sigma-Aldrich
水, tested according to Ph. Eur.
Sigma-Aldrich
E-Toxate 水, endotoxin, free
Supelco
水, for HPCE, for luminescence, suitable for UV/Vis spectroscopy
Supelco
密度标准品 998kg/m3, H&D Fitzgerald Ltd. Quality
Sigma-Aldrich
缬氨霉素, Ready Made Solution, ~1 mg/mL in DMSO
Sigma-Aldrich
低氘水, ≤1 ppm (Deuterium oxide)
Sigma-Aldrich
β-D-阿洛糖, rare aldohexose sugar
Sigma-Aldrich
水-16O, ≥99.94 atom % 16O